Market Place
Sourcing Support
Vetter Strengthens Senior Management for Sustainable Growth
21 Nov 2024 //
BUSINESSWIRE
Vetter`s European Clinical Site Successfully Completes First 100 Aseptic Fills
05 Sep 2024 //
BUSINESSWIRE
Advanced robotic system streamlines syringe processing
18 Jun 2024 //
PRESS RELEASE
Vetter experts share takeaways from Bio 2024
11 Jun 2024 //
PRESS RELEASE
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany
07 Jun 2024 //
BUSINESSWIRE
CDMO Vetter plans new sites in Illinois, Germany
07 Jun 2024 //
FIERCE PHARMA
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany
06 Jun 2024 //
BUSINESSWIRE
Vetter wins Best Managed Companies Award 2024
28 May 2024 //
BUSINESSWIRE
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023
08 May 2024 //
BUSINESSWIRE
Vetter Wins Top Honors In All Core Categories At 13th CDMO Leadership Awards
26 Mar 2024 //
PRESS RELEASE
5 key reasons you need a CDMO for your clinical trials
20 Mar 2024 //
PRESS RELEASE
Vetter Contributes to Commercial Launches of Eight Customer Products in 2023
14 Feb 2024 //
BUSINESSWIRE
Launching in an autoinjector: What to expect with a self-injection device
01 Feb 2024 //
PRESS RELEASE
Vetter Joins Science Based Targets Initiative (SBTi)
05 Dec 2023 //
BUSINESSWIRE
Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives
14 Jun 2023 //
BUSINESSWIRE
Steady growth, growing complexity: Key industry trends at BIO2023
13 Jun 2023 //
PRESS RELEASE
Gold status for Vetter: Named Best Managed Company for the fourth time
30 May 2023 //
PRESS RELEASE
Vetter Expands Clinical Development and Manufacturing Offerings
09 May 2023 //
CONTRACT PHARMA
Vetter Performs Extraordinarily with Six Wins in Annual CDMO Leadership Awards
28 Mar 2023 //
BUSINESSWIRE
Vetter`s Clinical Facility Helps Advance Client Products to Market
02 Feb 2023 //
CONTRACT PHARMA
Vetter Drives Its Sustainability Campaign Forward
11 Oct 2022 //
BUSINESSWIRE
MoonLake signs development and manufacturing agreement with Vetter Pharma
26 Jul 2022 //
GLOBENEWSWIRE
Vetter Publishes First Sustainability Report
01 Jun 2022 //
BUSINESSWIRE
Vetter Achieves Climate Neutrality Across All Sites
27 Sep 2021 //
CONTRACTPHARMA
Vetter chalks long-term sustainability strategy to become carbon neutral
24 Sep 2021 //
BIOSPECTRUMASIA
Vetter’s New Clinical Mfg. Site Now Fully Integrated
21 Jul 2021 //
CONTRACT PHARMA
Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria
08 Jul 2020 //
BIOPHARMAINTERNATIONAL
Vetter and Rentschler Team Up for Strategic Collaboration
06 Jul 2020 //
PHARMTECH
Vetter to Invest in Collaborative Work Robots
30 Oct 2019 //
CONTRACTPHARMA
Vetter securing customer commitments ahead of groundbreaking at US site
06 Feb 2018 //
OUTSOURCING
Vetter Introduces South Korea’s Pharma & Biotech Community
02 Feb 2018 //
B3CNEWS
Anvisa grants registration to drug Spinraza
26 Aug 2017 //
ANVISA
Vetter inks ‘pain-free’ needle deal to meet alternative drug delivery demand
05 Jun 2017 //
IN PHARMATECHNOLOGIST
German CDMO Migrates 800 Staff to Newly Opened €100m Packaging Site
27 Jan 2017 //
OUTSOURCING PHARMA
The FDA removes the contraindication for use of Bracco Diagnostics`s LUMASON
12 Jan 2017 //
PR NEWSWIRE
Vetter`s building binge continues with ground-breaking for another Schuetzenstrasse facility
25 Mar 2016 //
FIERCE PHARMA MANUFACTURING
